|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 38/26 | (2006.01) | ||
| C07K 14/605 | (2006.01) | ||
| C07K 14/00 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 1/00 | (2006.01) |
| (11) | Number of the document | 3310371 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16733268.3 |
| Date of filing the European patent application | 2016-06-16 | |
| (97) | Date of publication of the European application | 2018-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-30 |
| (46) | Date of publication of the claims translation | 2020-12-28 |
| (86) | Number | PCT/US2016/037818 |
| Date | 2016-06-16 |
| (87) | Number | WO 2016/209707 |
| Date | 2016-12-29 |
| (30) | Number | Date | Country code |
| 201562182847 P | 2015-06-22 | US |
| (72) |
CHEN, Yanyun, US
MEZO, Adam Robert, US
QU, Hongchang, US
VALENZUELA, Francisco Alcides, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Gliukakono ir GLP-1 koagonisto junginiai |
| GLUCAGON AND GLP-1 CO-AGONIST COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 10 | 231.00 EUR |
| 2026-06-16 |